SCP2
SCP2 (sterol carrier protein 2, also known as nsLTP, SCPx and SCP-X) is an intracellular lipid transfer protein that mediates the movement of phospholipids, cholesterol and gangliosides. The SCP2 gene also encodes a longer form, SCPx, a peroxisome-associated thiolase involved in fatty acid oxidation. Browse Assay Genie's current range of SCP2 research reagents below, or read on for the biology behind the target.
SCP2 mediates the transfer of all common phospholipids, cholesterol and gangliosides from the endoplasmic reticulum to the plasma membrane. It may play a role in regulating steroidogenesis and stimulates the microsomal conversion of 7-dehydrocholesterol to cholesterol. The protein also binds fatty acids and fatty acyl Coenzyme A (CoA) species such as phytanoyl-CoA. In the endoplasmic reticulum it is involved in regulating phospholipid synthesis, enhancing the incorporation of exogenous fatty acid into glycerides, and it appears to stimulate the rate-limiting step in phosphatidic acid formation mediated by GPAT3.
The SCP2 gene encodes two proteins from two independently regulated promoters: sterol carrier protein X (SCPx) from the proximal promoter and the shorter sterol carrier protein 2 from the distal promoter. The two share a common C-terminus. SCPx is a peroxisome-associated thiolase involved in the oxidation of branched-chain fatty acids, while the shorter SCP2 protein is thought to act as an intracellular lipid transfer protein. The two isoforms cooperate in peroxisomal oxidation of certain naturally occurring tetramethyl-branched fatty acyl-CoAs. The N-terminal section belongs to the thiolase-like superfamily, thiolase family, and alternative splicing produces multiple transcript variants, some encoding different isoforms. UniProt reports the protein in the peroxisome, cytoplasm, mitochondrion and endoplasmic reticulum.
The gene is highly expressed in organs involved in lipid metabolism. It may also play a role in Zellweger syndrome, a condition in which cells are deficient in peroxisomes and have impaired bile acid synthesis. HGNC places SCP2 in the SCP2 domain containing gene group. The aliases nsLTP, SCPx and SCP-X reflect the protein's non-specific lipid transfer activity and its two forms.
SCP2 mediates transfer of phospholipids, cholesterol and gangliosides from the endoplasmic reticulum to the plasma membrane, making it a focus for studies of lipid movement.
SCPx acts as a peroxisome-associated thiolase in branched-chain fatty acid oxidation, including tetramethyl-branched fatty acyl-CoAs.
SCP2 stimulates microsomal conversion of 7-dehydrocholesterol to cholesterol and may play a role in regulating steroidogenesis.
The gene may play a role in Zellweger syndrome, where peroxisome-deficient cells show impaired bile acid synthesis.
SCP2 mediates the transfer of phospholipids, cholesterol and gangliosides from the endoplasmic reticulum to the plasma membrane. It also binds fatty acids and fatty acyl-CoAs, stimulates conversion of 7-dehydrocholesterol to cholesterol, and enhances phosphatidic acid formation mediated by GPAT3.
The SCP2 gene has two promoters. The proximal promoter produces the longer sterol carrier protein X (SCPx, SCP-X), a peroxisomal thiolase, and the distal promoter produces the shorter SCP2 protein. The two share a common C-terminus. The alias nsLTP denotes non-specific lipid-transfer protein.
NCBI Gene reports that SCP2 is highly expressed in organs involved in lipid metabolism and may play a role in Zellweger syndrome, in which cells lack peroxisomes and have impaired bile acid synthesis. Check the datasheet of any product for its validated reactivity.
Other thiolases, peroxisomal enzymes and lipid-metabolism proteins connected to SCP2 biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P22307; product specifications from Assay Genie datasheets.